MAP2 is differentially phosphorylated in schizophrenia, altering its function
Melanie J. Grubisha, X. Sun, M L MacDonald, Megan E. Garver, Z. Sun, K. A. Paris, D. S. Patel, Rebecca A. DeGiosio, David A. Lewis, N. A. Yates, Carlos Jaime Camacho, Gregg E. Homanics, Ying Ding, Robert A. Sweet
This study identifies MAP2 phosphorylation changes in schizophrenia, linking them to neuronal structure and synaptic function impairments through phosphoproteomics and transgenic mouse models.
Molecular Psychiatry · Feb 1, 2021Peer-reviewedNeuroscience